Literature DB >> 11015431

Granulomatous amebic encephalitis in a patient with AIDS: isolation of acanthamoeba sp. Group II from brain tissue and successful treatment with sulfadiazine and fluconazole.

M Seijo Martinez1, G Gonzalez-Mediero, P Santiago, A Rodriguez De Lope, J Diz, C Conde, G S Visvesvara.   

Abstract

A patient with AIDS, treated with highly active antiretroviral therapy and trimethoprim-sulfamethoxazole, presented with confusion, a hemifield defect, and a mass lesion in the right occipital lobe. A brain biopsy confirmed granulomatous amebic encephalitis (GAE) due to Acanthamoeba castellanii. The patient was treated with fluconazole and sulfadiazine, and the lesion was surgically excised. This is the first case of AIDS-associated GAE responding favorably to therapy. The existence of a solitary brain lesion, absence of other sites of infection, and intense cellular response in spite of a very low CD4 count conditioned the favorable outcome. We review and discuss the diagnostic microbiologic options for the laboratory diagnosis of infections due to free-living amebae.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11015431      PMCID: PMC87504     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  26 in total

1.  HAART improves prognosis in HIV-associated progressive multifocal leukoencephalopathy.

Authors:  D B Clifford; C Yiannoutsos; M Glicksman; D M Simpson; E J Singer; P J Piliero; C M Marra; G S Francis; J C McArthur; K L Tyler; A C Tselis; N E Hyslop
Journal:  Neurology       Date:  1999-02       Impact factor: 9.910

2.  HARTMANELLA CASTELLANI (ACANTHAMOEBA SP): PRELIMINARY REPORT ON EXPERIMENTAL CHEMOTHERAPY.

Authors:  C G CULBERTSON; D H HOLMES; W M OVERTON
Journal:  Am J Clin Pathol       Date:  1965-04       Impact factor: 2.493

3.  Disseminated acanthamebiasis in patients with AIDS. A report of five cases and a review of the literature.

Authors:  G J Murakawa; T McCalmont; J Altman; G H Telang; M D Hoffman; G R Kantor; T G Berger
Journal:  Arch Dermatol       Date:  1995-11

Review 4.  Free-living, amphizoic and opportunistic amebas.

Authors:  A J Martinez; G S Visvesvara
Journal:  Brain Pathol       Date:  1997-01       Impact factor: 6.508

5.  Acanthamoeba castellanii: growth, encystment, excystment and biocide susceptibility.

Authors:  W Khunkitti; D Lloyd; J R Furr; A D Russell
Journal:  J Infect       Date:  1998-01       Impact factor: 6.072

6.  Effect of HAART on natural history of AIDS-related opportunistic disorders.

Authors:  K A Sepkowitz
Journal:  Lancet       Date:  1998-01-24       Impact factor: 79.321

Review 7.  Isolation, identification and increasing importance of 'free-living' amoebae causing human disease.

Authors:  Z Szénási; T Endo; K Yagita; E Nagy
Journal:  J Med Microbiol       Date:  1998-01       Impact factor: 2.472

8.  Amebic osteomyelitis in a child with acquired immunodeficiency syndrome: a case report.

Authors:  D M Selby; R S Chandra; T A Rakusan; B Loechelt; B M Markle; G S Visvesvara
Journal:  Pediatr Pathol Lab Med       Date:  1998 Jan-Feb

9.  Cerebral amebiasis in the acquired immunodeficiency syndrome.

Authors:  E E Calore; M J Cavaliere; N M Calore
Journal:  Acta Neurol Belg       Date:  1997-12       Impact factor: 2.396

10.  Treatment of HIV-1-associated microsporidiosis and cryptosporidiosis with combination antiretroviral therapy.

Authors:  A Carr; D Marriott; A Field; E Vasak; D A Cooper
Journal:  Lancet       Date:  1998-01-24       Impact factor: 79.321

View more
  38 in total

1.  In vitro amoebicidal activities of Satureja cuneifolia and Melissa officinalis on Acanthamoeba castellanii cysts and trophozoites.

Authors:  E Malatyali; B Tepe; S Degerli; S Berk
Journal:  Parasitol Res       Date:  2011-12-09       Impact factor: 2.289

2.  Survival of an AIDS patient after infection with Acanthamoeba sp. of the central nervous system.

Authors:  Hana El Sahly; Michelle Udayamurthy; George Parkerson; Rodrigo Hasbun
Journal:  Infection       Date:  2017-06-21       Impact factor: 3.553

3.  Isolation and identification of pathogenic Acanthamoeba strains in Tenerife, Canary Islands, Spain from water sources.

Authors:  Jacob Lorenzo-Morales; Antonio Ortega-Rivas; Pilar Foronda; Enrique Martínez; Basilio Valladares
Journal:  Parasitol Res       Date:  2005-01-28       Impact factor: 2.289

4.  Disseminated Balamuthia mandrillaris Infection.

Authors:  Katherine R Schafer; Neil Shah; M I Almira-Suarez; Jennifer M Reese; George M Hoke; James W Mandell; Sharon L Roy; Govinda Visvesvara
Journal:  J Clin Microbiol       Date:  2015-07-01       Impact factor: 5.948

Review 5.  The Development of Drugs against Acanthamoeba Infections.

Authors:  Ruqaiyyah Siddiqui; Yousuf Aqeel; Naveed Ahmed Khan
Journal:  Antimicrob Agents Chemother       Date:  2016-10-21       Impact factor: 5.191

6.  In vitro amoebicidal activities of Teucrium polium and T. chamaedrys on Acanthamoeba castellanii trophozoites and cysts.

Authors:  Bektas Tepe; Erdogan Malatyali; Serpil Degerli; Seyda Berk
Journal:  Parasitol Res       Date:  2011-10-26       Impact factor: 2.289

7.  Molecular characterization of Acanthamoeba isolated in water treatment plants and comparison with clinical isolates.

Authors:  A Magnet; A L Galván; S Fenoy; F Izquierdo; C Rueda; C Fernandez Vadillo; J Pérez-Irezábal; K Bandyopadhyay; G S Visvesvara; A J da Silva; C del Aguila
Journal:  Parasitol Res       Date:  2012-03-07       Impact factor: 2.289

8.  [Acanthamoeba meningoencephalitis: a case in an adolescent female patient with systemic lupus erythematosus].

Authors:  P Lange; C Bauer; M Hügens-Penzel; H W Lehmann; K-P Zimmer; K Kuchelmeister
Journal:  Pathologe       Date:  2008-11       Impact factor: 1.011

9.  Diagnosis of infections caused by pathogenic free-living amoebae.

Authors:  Bruno da Rocha-Azevedo; Herbert B Tanowitz; Francine Marciano-Cabral
Journal:  Interdiscip Perspect Infect Dis       Date:  2009-08-02

10.  Successful treatment of disseminated Acanthamoeba sp. infection with miltefosine.

Authors:  Alexander C Aichelburg; Julia Walochnik; Ojan Assadian; Helmut Prosch; Andrea Steuer; Gedeon Perneczky; Govinda S Visvesvara; Horst Aspöck; Norbert Vetter
Journal:  Emerg Infect Dis       Date:  2008-11       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.